Tickwind
TodayOpportunitiesMarketsAI Chat
EN
Log inSign up
Tickwind

Read every tick. See where the market's blowing.

  • X
  • TelegramChinese
  • Newsletter

Product

  • Markets
  • Theme Zones
  • All stocks
  • Compare
  • Hot stocks
  • Opportunities
  • News
  • Discussion
  • Watchlist
  • What's new

Account

  • Settings
  • Newsletter
  • For writers
  • MCP server
  • Contact
  • Log in
  • Sign up
MarketsTheme ZonesAll stocksCompareHot stocksOpportunitiesNewsDiscussionWatchlistWhat's newSettingsNewsletterFor writersMCP serverContactLog inSign up

© 2026 Tickwind. Not investment advice.

Made for the curious investor.

Home/NSRX/Revenue

Nasus Pharma Ltd (NSRX) Revenue

Nasus Pharma Ltd (NSRX) annual revenue history from SEC filings — each fiscal year as reported, with year-over-year change.

$1.2BFY2025
25
Fiscal yearValueYoY
FY2025$1.2B—

Source: SEC XBRL filings · For reference only · Not investment advice

More NSRX financial trends

NSRX Net incomeNSRX Net marginNSRX Gross profitNSRX Gross marginNSRX Operating incomeNSRX Operating marginNSRX Operating cash flowNSRX Free cash flowNSRX Capital expendituresNSRX Return on equityNSRX Stock buybacksNSRX Dividends paidNSRX Total assetsNSRX Total liabilitiesNSRX Shareholders’ equityNSRX overview →